Anti-TNF agents ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
271	強直性脊椎炎	2

271. 強直性脊椎炎

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04943237 (ClinicalTrials.gov)	July 1, 2019	19/6/2021	Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis	Anti-TNF Therapy and Nerve Conduction Studies in Patients With Ankylosing Spondylitis	Anti - TNF Therapy;Ankylosing Spondylitis;Neuropathy	Drug: Anti-TNF agents;Drug: Conventional therapy users for the last 5 years	Istanbul Physical Medicine Rehabilitation Training and Research Hospital	NULL	Completed	20 Years	65 Years	All	60		Turkey
2	NCT03470688 (ClinicalTrials.gov)	March 1, 2018	6/3/2018	Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents	An Observational Study Designed to Investigate the Utilisation and Effectiveness of Originator and B ...	Rheumatoid Arthritis;Psoriatic Arthritis;Ankylosing Spondylitis	Biological: Originator;Biological: Biosimilar	Opal Rheumatology Ltd.	Merck Sharp & Dohme Corp.	Recruiting	18 Years	N/A	All	5000		Australia

First Previous1Next Last